CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Income Taxes
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Income Taxes of $30.33 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2017-05-11
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for the quarter ending 2017-03-31 was $30.33K, a 32.88% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for the quarter ending 2016-12-31 was $243.13K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for the quarter ending 2016-09-30 was $20.80K, a 96.74% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for the quarter ending 2016-06-30 was $21.42K, a 10.23% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for fiscal 2016 was $308.18K, a 409.89% increase from fiscal 2015.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for fiscal 2015 was $60.44K, a 21.55% decline from fiscal 2014.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in income taxes for fiscal 2014 was $77.04K.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month | Increase (Decrease) in Income Taxes 12 month |
|---|---|---|---|---|
| 2017-03-31 | $30.33K 10-Q · filed 2017-05-11 | $273.46K derived: sum of 2 quarters · filed 2017-05-11 | $294.26K derived: sum of 3 quarters · filed 2017-05-11 | $315.68K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | $243.13K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $263.93K derived: sum of 2 quarters · filed 2017-03-31 | $285.35K derived: sum of 3 quarters · filed 2017-03-31 | $308.18K 10-K · filed 2017-03-31 |
| 2016-09-30 | $20.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $42.22K derived: sum of 2 quarters · filed 2016-11-14 | $65.04K 10-Q · filed 2016-11-14 | -$551.73K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-06-30 | $21.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $44.24K 10-Q · filed 2016-08-11 | -$572.53K derived: sum of 3 quarters · filed 2017-05-11 | $65.97K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-03-31 | $22.83K 10-Q · filed 2017-05-11 | -$593.94K derived: sum of 2 quarters · filed 2017-05-11 | $44.55K derived: sum of 3 quarters · filed 2017-05-11 | $63.98K derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | -$616.77K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $21.73K derived: sum of 2 quarters · filed 2017-03-31 | $41.16K derived: sum of 3 quarters · filed 2017-03-31 | $60.44K 10-K · filed 2017-03-31 |
| 2015-09-30 | $638.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $657.92K derived: sum of 2 quarters · filed 2016-11-14 | $677.21K 10-Q · filed 2016-11-14 | |
| 2015-06-30 | $19.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $38.71K 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | $19.28K 10-Q · filed 2016-05-16 | |||
| 2014-12-31 | $77.04K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |